Niftypharma
Sun Pharma Tests Key Resistance LevelMonthly Charts force us to take a step back and give us no choice but to identify the direction of the primary trends. We use these charts to put shorter-term trends into context and this exercise is particularly useful when the market is experiencing heightened volatility. Nifty Pharma has been a great winner for us longer-term, and despite our near-term view of caution on the sector, we continue to view its trend on an absolute and relative basis constructive. Its largest holding, Sun Pharma, has been unable to reclaim former support/resistance near 475 just yet, but if and when that does happen, it’ll be a major tailwind for the sector at large. This stock is one to watch in May as it attempts to confirm the start of a new uptrend by closing above 475.
AUROPHARMA KEY LEVELS SUPPORT AND RESISTANCE 20/04/2020Key Levels for AUROPHARMA:
UPPER BREAKOUT~555
FIRST TARGET~565.90
INTERIM RESISTANCE~576.05
FINAL RESISTANCE~587.45
****************************
LOWER BREAKOUT~534.30
FIRST TARGET~523.45
INTERIM SUPPORT~510.85
FINAL SUPPORT~498.25
Please trade with caution and consult your financial adviser before trading.
AUROPHARMA KEY LEVELS SUPPORT AND RESISTANCE 17/04/2020Key Levels for AUROPHARMA :
UPPER BREAKOUT~557.25
FIRST TARGET~576.40
INTERIM RESISTANCE~590.20
FINAL RESISTANCE~604.80
*****************************
LOWER BREAKOUT~536.10
FIRST TARGET~518.05
INTERIM SUPPORT~496.40
FINAL SUPPORT~480.20
Please trade with caution and consult your financial adviser before trading.
AUROPHARMA KEY LEVELS SUPPORT AND RESISTANCE 15/04/2020Key Levels for AUROPHARMA :
Upper Breakout~518.80
First Target~534.20
Interim Resistance~550.50
Final Resistance~565.90
**Lower Levels**
Lower Breakout~488.05
First Target~474.60
Interim Support~460
Final Support~441
Please trade with caution and consult your financial adviser before trading.
Nifty Pharma - ready to move up after a consolidation.Following Nifty ATH, other sectoral indices too are moving up, forming multiple bullish patterns.
Pharma sector which was once darling of investors, is attempting to catch up. Some of you might have experienced, how it makes wild moves. Pharma stocks are among most preferred ones, among FIIs, DIIs and HNIs.
I guess having exposure to the sector is a necessary for every equity portfolio. Identify a mix of large and quality mid cap stocks and keep adding them at every dip.